BiotechTube
Home/Hillhurst Biopharmaceuticals/Andrew Gomperts
AG

Andrew Gomperts

President and Chief Executive Officer

Hillhurst Biopharmaceuticals

Therapeutic Areas

Sickle Cell DiseaseParkinson's DiseaseAcute PainDiabetic Retinopathy

Hillhurst Biopharmaceuticals Pipeline

DrugIndicationPhase
HBI-002Parkinson's DiseasePhase 2a
UndisclosedSickle Cell DiseasePreclinical or Phase 1

Leadership Team at Hillhurst Biopharmaceuticals

AA
Alison Arter
Chief Commercial Officer
KB
Kevin Bracken
Senior Chemistry, Manufacturing, and Controls Advisor
BM
Bonnie Mills, PhD
Vice President, Regulatory Affairs
View full Hillhurst Biopharmaceuticals profile